Patent Assignment
Reel/Frame 016793/0789
Change of Name
Recorded: 2005-11-18
Received: 2005-11-18
Pages: 36
Assignor
AVENTIS PHARMA DEUTSCHLAND GMBH
Executed: 2005-09-01
Assignee
SANOFI-AVENTIS DEUTSCHLAND GMBH
BRUNINGSTRASSE 50, FRANKFURT AM MAIN, DEX, D-65929, GERMANY
Covered Properties
(100)
Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders
Application:
11/231,221 →
Substituted Indoles
Application:
11/187,396 →
Method of activating insulin receptor substrate-2 to stimulate insulin production
Application:
11/179,972 →
Use of SNPs of MCH-R for identifying genetic disorders in maintaining the normal body weight
Application:
11/155,419 →
Method for Screening for Activators of Soluble Guanylate Cyclase Having Oxidized Heme Iron
Application:
11/144,265 →
Identification and purification of higher order transcription complexes from transgenic non-human animals
Application:
11/137,671 →
Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals
Application:
11/132,016 →
Miniaturized microtiter plate for HT-screening
Application:
11/121,536 →
Use of Vasopeptidase Inhibitors in the Treatment of Metabolic Diseases, Nephropathy and Advanced Glycation End-Product Associated Diseases
Application:
11/096,790 →
Acidic Insulin Preparations Having Improved Stability
Application:
11/089,777 →
Process for Identifying Substances Which Modulate the Activity of Hyperpolarization-Activated Cation Channels
Application:
11/088,356 →
Antisense oligonucleotides against tenascin for the treating of vitiligo
Application:
11/073,230 →
Process for Identifying Modulators of G-Protein-Coupled Receptors
Application:
11/060,023 →
Anthranilamides with Heteroarylsulfonyl Side Chain, Process of Preparation, and Use
Application:
11/052,959 →
Novel C. Elegans P21-Activated Kinase (Pak) Gene and Associated Loss-of-Function Phenotypes That Facilitate Screening for Small Molecule Modulators of Pak Activity in the Nematode, Caenorhabditis Elegans
Application:
11/045,439 →
Indazole Derivatives as Inhibitors of Hormone Sensitive Lipase
Application:
11/042,565 →
Cycloalkyl-Substituted 7-Amino-4-Quinolone-3-Carboxylic Acid Derivatives, Process for Their Preparation and Their Use as Medicaments
Application:
11/042,770 →
7-Phenylamino-4-Quinolone-3-Carboxylic Acid Derivatives, Process for Their Preparation and Their Use as Medicaments
Application:
11/042,023 →
Heterocyclically Substituted 7-Amino-4-Quinolone-3-Carboxylic Acid Derivatives, Process for Their Preparation and Their Use as Medicaments
Application:
11/042,589 →
Oxybenzamide Derivatives Useful for Inhibiting Factor Xa or Vlla
Application:
11/039,107 →
Process for Stabilizing 4-Halopyridines
Application:
11/035,142 →
Aequorin as a Growth Marker in Yeast
Application:
11/011,349 →
Medicinal lipolysis of accumulations of fat
Application:
11/011,333 →
Use of C2-Substituted Indan-1-Ol Systems for Preparing Medicaments for the Prophylaxis or Treatment of Obesity
Application:
11/006,164 →
Process for Preparing (3-Oxo-2,3-Dihydro-1H-Isoindol-1-Yl) Acetylguanidine Derivatives
Application:
11/001,624 →
Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease
Application:
10/991,172 →
Ortho-Substituted Pentafluorosulfanylbenzenes, Process for Their Preparation and Their Use as Valuable Synthetic Intermediates
Application:
10/989,027 →
Process for Preparing 4-Pentafluorosulfanylbenzoylguanidines
Application:
10/988,971 →
Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same
Application:
10/989,069 →
C2-Substituted Idan-1-Ols and Their Derivatives, Processes for Their Preparation and Their Use as Pharmaceuticals
Application:
10/981,045 →
Process for Preparing Cyclic N-Substituted Alpha-Imino Carboxylic Acids
Application:
10/981,120 →
Use of Enos Transcription Enhancers in the Cell Therapy of Ischemic Heart Diseases
Application:
10/979,399 →
Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
Application:
10/978,674 →
Methods of using and preparing thiolutin dioxide
Application:
10/973,309 →
2-Phenylbenzofuran Derivatives, a Process for Preparing Them, and Their Use
Application:
10/972,546 →
Bengamide Derivatives, Process for Preparing Them, and Their Use
Application:
10/971,228 →
Medicinal targeted local lipolysis
Application:
10/970,815 →
Bicyclic Imino Acid Derivatives as Inhibitors of Matrix Metalloproteinases
Application:
10/950,802 →
Identification of ses-3 and the uses of the same
Application:
10/481,581 →
Substituted an Unsubstituted Benzooxathiazoles and Compounds Derived Therefrom
Application:
10/939,936 →
Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
Application:
10/932,431 →
High-Throughput-Assay with High Sensitivity for Measuring of the Activity of Beta-Adrenergic Receptor Kinase and for Determining the Impact of Test Substances on Such Activity
Application:
10/931,161 →
Test system for the identification of APJ receptor ligands
Application:
10/931,080 →
New indole derivatives as factor Xa inhibitors
Application:
10/926,909 →
Substituted Thienoimidazoles Useful for Disease Treatment and Prevention
Application:
10/926,118 →
Identification of ses-1 and the uses of the same
Application:
10/481,582 →
Pentafluorosulfanylphenyl-Substituted Benzoylguanidines, Processes for Their Preparation, Their Use as Medicament or Diagnostic Aid, and Medicament Comprising Them
Application:
10/918,902 →
Method for Identifying Irs Inhibitors or Agonists
Application:
10/918,015 →
Pharmaceutical Composition Comprising a Sodium Hydrogen Exchange Inhibitor and an Angiotensin Converting Enzyme Inhibitor
Application:
10/910,912 →
Substituted Benzoylureido-O-Benzoylamides, Process for Their Preparation and Their Use
Application:
10/899,868 →
Substituted Thiazole-Benzoisothiazole Dioxide Derivatives, Process for Their Preparation and Their Use
Application:
10/899,620 →
Cyanopyrrolidides, Process for Their Preparation and Their Use as Medicaments
Application:
10/898,752 →
Novel Bicyclic Cyanoheterocycles, Process for Their Preparation and Their Use as Medicaments
Application:
10/898,751 →
Perfusion process for producing erythropoietin
Application:
10/896,660 →
Use of Pak Inhibitor for the Treatment of a Joint Disease
Application:
10/893,025 →
Substituted Imidazolidines, Process for Their Preparation, and Their Use as a Medicament or Diagnostic, and Medicament Comprising Them
Application:
10/892,994 →
Guanidine and Amidine Derivatives as Factor Xa Inhibitors
Application:
10/886,312 →
Cap for Injection Devices
Application:
10/866,904 →
Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
Application:
10/866,843 →
Derivatives of 3-(Guanidinocarbonyl) Heterocycle, Methods of Preparation and Intermediates Thereof, Their Use as Medicaments, and Pharmaceutical Compositions Therefrom
Application:
10/865,454 →
Polyamide Nucleic Acid Derivatives, and Agents, and Processes for Preparing Them
Application:
10/863,999 →
Method and device for the quantitative analysis of solutions and dispersions by means of near infrared spectroscopy
Application:
10/861,675 →
Acylated 6,7,8,9-Tetrahydro-5H-Benzocycloheptenyl Amines and Their Use as Pharmaceutical Agents
Application:
10/859,773 →
Polyamide nucleic acid derivatives, and agents, and processes for preparing them
Application:
10/858,658 →
2-Amino-1,3-Propanediol Compounds for the Treatment of Acute Pain
Application:
10/853,761 →
Method for Alleviating Pain Using Sphingosine-1-Phosphate and Related Compounds, and Assays for Identifying Such Compounds
Application:
10/850,586 →
Method for alleviating pain using protein associated with MYC and related compounds, and assays for identifying such compounds
Application:
10/850,591 →
Indazole-Derivatives as Factor Xa Inhibitors
Application:
10/849,088 →
Use of Irs-Polypeptides for Identifying of Pharmaceutically Active Compounds
Application:
10/849,424 →
A Method of Screening for Gamma-Secretase Activity
Application:
10/849,423 →
Azaindole-Derivatives as Factor Xa Inhibitors
Application:
10/849,089 →
Benzimidazole-Derivatives as Factor Xa Inhibitors
Application:
10/849,436 →
Triazole-Derivatives as Blood Clotting Enzyme Factor Xa Inhibitors
Application:
10/848,916 →
Indole Derivatives as Factor Xa Inhibitors
Application:
10/848,743 →
Process for synthesizing heterocyclic compounds
Application:
10/840,105 →
Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders
Application:
10/831,552 →
Crystal Form of N-(4-Trifluoromethylphenyl)-5-Methylisoxazole-4-Carboxamide
Application:
10/830,307 →
Process for the Production of Piperidine Derivatives
Application:
10/829,803 →
Triaza- and Tetraaza-Anthracenedione Derivatives, Their Preparation and Their Use as Pharmaceuticals
Application:
10/829,064 →
Method for the Identification of a Risk for a Thrombogenic Disorder by Determining the Tafi-IIE347 Polymorphism
Application:
11/184,010 →
Nover Diphenylazetidinone with Improved Physiological Properties, Process for Its Preparation, Medicaments Comprising This Compound, and Its Use
Application:
10/813,954 →
Composition, Process of Making, and Medical Use of Substituted 4-Phenyltetrahydroisoquinolines
Application:
10/807,781 →
Synthesis of 2-Chloromethyl-6-Methylbenzoic Ester
Application:
10/803,578 →
Process for Preparing 2-Cyano-3-Hydroxy-N-(Phenyl)But-2-Enamides
Application:
10/802,583 →
Process for the Stabilization of Proteins in an Aqueous Solution Comprising Cysteine in a Concentration Between 150 and 220MM
Application:
10/796,160 →
2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxypyridin-3-yl)propyl] benzamide, its use as a medicament, and pharmaceutical preparations comprising it
Application:
10/796,466 →
Combination of Phenylcarboxamides with Blockers of the Ikr Channel and Their Use for the Treatment of Atrial Arrhythmias
Application:
10/796,894 →
Substituted Benzoylureidopyridylpiperidine-and-Pyrrolidinecarboxylic Acid Derivatives, Processes for Preparing Them and Their Use
Application:
10/795,863 →
Arylcycloalkyl-Substituted Alkanoic Acid Derivatives, Processes for Their Preparation and Their Use as Pharmaceuticals
Application:
10/789,017 →
Cycloalkyl Derivatives Having Bioisosteric Carboxylic Acid Groups, Processes for Their Preparation and Their Use as Pharmaceuticals
Application:
10/789,865 →
1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
Application:
10/789,281 →
Cycloalkylmethoxy-Substituted Acetic Acid Derivatives, Processes for Their Preparation and Their Use as Pharmaceuticals
Application:
10/788,996 →
Process for Preparing the Enantiomeric Forms of Cis-Configured 1,3-Cyclohexanediol Derivatives
Application:
10/789,053 →
Cycloalkyl-Substituted Alkanoic Acid Derivatives, Processes for Their Preparation and Their Use as Pharmaceuticals
Application:
10/789,324 →
Diarylcycloalkyl Derivatives, Process for Their Preparation and Their Use as Pharmaceuticals
Application:
10/789,019 →
Arylcycloalkyl Derivatives Having Branched Side Chains, Processes for Their Preparation and Their Use as Pharmaceuticals
Application:
10/789,323 →
Cycloalkyl-Substituted Amino Acid Derivatives, Processes for Their Preparation and Their Use as Pharmaceuticals
Application:
10/788,997 →
Substituted 3-(Benzoylureido) Thiophene Derivatives, Processes for Preparing Them and Their Use
Application:
10/780,344 →
Nitrogen-Substituted Hexahydropyrazino[1,2-a]Pyrimidine-4,7-Dione Derivatives, Processes for Their Preparation and Their Use as Medicaments
Application:
10/779,439 →
Substituted Hexahydropyrazino [1,2-a] Pyrimidine-4,7-Dione Derivatives, Process for Their Preparation and Their Use as Medicaments
Application:
10/778,554 →